The IL-6 receptor super-antagonist Sant7 enhances antiproliferative and apoptotic effects induced by dexamethasone and zoledronic acid on multiple myeloma cells.

International journal of oncology

Volumn 21, Issue 4, 2002, Pages 867-873

  Tassone, Pierfrancesco ^a   Galea, Eulalia ^a   Forciniti, Samantha ^a   Tagliaferri, Pierosandro ^a   Venuta, Salvatore ^a  

^a Department of Experimental and Clinical Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BISPHOSPHONIC ACID DERIVATIVE; DEXAMETHASONE; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MEMBRANE PROTEIN; PROTEOGLYCAN; SANT 7; SANT-7; SYNDECAN; ZOLEDRONIC ACID;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; MULTIPLE MYELOMA; TIME;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; CELL DIVISION; DEXAMETHASONE; DIPHOSPHONATES; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; IMIDAZOLES; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA; PROTEOGLYCANS; RECEPTORS, INTERLEUKIN-6; SYNDECANS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036782532     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.21.4.867     Document Type: Article

References (0)